To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Beverly biotech is working ...

Seventy-three pharmaceutical, biotechnology and medical device companies from mainland China filed for IPOs in Hong Kong this year, a review by BioWorld found. In the second half of 2025, 43 new ...

JM Group Limited (NYSE:JMG) IPO will take place December, 09 on the NYSE exchange under the ticker JMG. The company is offering shares at an expected price between $4.00 and $5.00 per share with an ...

Biotech startup Evommune and diagnostics company BillionToOne expect to begin trading on public exchanges today, giving investors hope that initial public offerings in the life sciences are poised for ...

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 to $17 per share. The California biotech announced its IPO intentions ...

MapLight Therapeutics Inc. shares jumped as much as 23% after the biotechnology firm raised $258.9 million in an initial public offering and private placement. Shares of the Redwood City, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Charming Medical Limited Class A ( (MCTA) ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Founded in 2019, Enveda claimed ...

Will the return of biotech IPOs become the hottest fashion trend this fall? It’s still early in the season, but Evommune has become the latest indicator that drug developers are once again tempted by ...

In the past week or so, a couple of initial public offerings prompted huge insider buying. However, these were not the only notable insider purchases recently. If you’re thinking about retiring or ...

Megan Holdings Limited (NASDAQ: MGN) IPO will take place September, 26 on the NASDAQ exchange under the ticker MGN. The company is offering shares at an expected price between $4.00 and $6.00 per ...

LB Pharmaceuticals aims to show that what is old can become new again with a lead drug candidate that’s a modified version of a decades-old schizophrenia medication from Sanofi. The strategy is ...